Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 075993
Company: LANNETT CO INC

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
LACTULOSE LACTULOSE 10GM/15ML SOLUTION;ORAL Prescription AA No No

Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
07/26/2001 ORIG-1 Approval

Label is not available on this site.

LACTULOSE

SOLUTION;ORAL; 10GM/15ML
TE Code = AA

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CONSTILAC LACTULOSE 10GM/15ML SOLUTION;ORAL Prescription No AA 071054 ALRA
LACTULOSE LACTULOSE 10GM/15ML SOLUTION;ORAL Prescription No AA 074076 AKORN
LACTULOSE LACTULOSE 10GM/15ML SOLUTION;ORAL Prescription No AA 209517 CHARTWELL RX
LACTULOSE LACTULOSE 10GM/15ML SOLUTION;ORAL Prescription No AA 090503 FRESENIUS KABI
LACTULOSE LACTULOSE 10GM/15ML SOLUTION;ORAL Prescription No AA 075993 LANNETT CO INC
LACTULOSE LACTULOSE 10GM/15ML SOLUTION;ORAL Prescription No AA 074623 PHARM ASSOC
LACTULOSE LACTULOSE 10GM/15ML SOLUTION;ORAL Prescription No AA 074138 VISTAPHARM
LACTULOSE LACTULOSE 10GM/15ML SOLUTION;ORAL Prescription No AA 074602 WOCKHARDT BIO AG
LACTULOSE LACTULOSE 10GM/15ML SOLUTION;ORAL Prescription No AA 075911 XTTRIUM LABS INC

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English